Levels of Visfatin/NAMPT in Human Milk

NCT06487286 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 30

Last updated 2024-11-14

No results posted yet for this study

Summary

Visfatin, released in maternal milk at different concentrations related to the maternal conditions, could act as a biomarker with a prognostic/predictive value to determine different newborn clinical conditions, particularly the weight loss of the neonate.

Conditions

  • Visfatin Levels in Maternal Milk Samples
  • Birth Weight

Interventions

OTHER

observational study

observational study

Sponsors & Collaborators

  • Università degli Studi del Piemonte Orientale Amedeo Avogadro

    collaborator OTHER
  • Paolo Manzoni Study Group

    lead OTHER

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-10-24
Primary Completion
2025-04-23
Completion
2025-04-23

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06487286 on ClinicalTrials.gov